EI
SYRS

EAM Investors’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

EAM Investors’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-84,002
Closed -$654K – 345
2023
Q4 		$654K Buy
+84,002
New +$654K 0.12% 203